ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LMNX Luminex Corporation

36.99
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Luminex Corporation NASDAQ:LMNX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 36.99 36.94 36.98 0 01:00:00

Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference

04/09/2015 1:30pm

PR Newswire (US)


Luminex (NASDAQ:LMNX)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Luminex Charts.

AUSTIN, Texas, Sept. 4, 2015 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Morgan Stanley Global Healthcare Conference to be held September 16 - 18, 2015, at the Grand Hyatt Hotel in New York City.

Luminex logo.

The investor presentation will begin at 11:40 a.m. Eastern time on Friday, September 18, 2015.  The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

ABOUT LUMINEX CORPORATION

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.

Contacts:

 Harriss T. Currie



 Sr. Vice President, Finance and CFO   



 512-219-8020



 hcurrie@luminexcorp.com         



 

Matt Scalo



Sr. Director, Investor Relations



512-219-8020



mscalo@luminexcorp.com  


Logo - http://photos.prnewswire.com/prnh/20150201/172702LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/luminex-corporation-to-present-at-the-morgan-stanley-global-healthcare-conference-300138086.html

SOURCE Luminex Corporation

Copyright 2015 PR Newswire

1 Year Luminex Chart

1 Year Luminex Chart

1 Month Luminex Chart

1 Month Luminex Chart